Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.65 USD | +5.58% | +3.11% | -35.21% |
May. 13 | Morgan Stanley Lowers Price Target on Organogenesis Holdings to $3 From $3.50, Keeps Equalweight Rating | MT |
May. 10 | Health Care Edges Higher Amid Rotation to Utilities - Health Care Roundup | DJ |
Financials (USD)
Sales 2024 * | 456M | Sales 2025 * | 477M | Capitalization | 333M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 7M | EV / Sales 2024 * | 0.71 x |
Net cash position 2024 * | 9.83M | Net cash position 2025 * | 24.56M | EV / Sales 2025 * | 0.65 x |
P/E ratio 2024 * |
-251
x | P/E ratio 2025 * |
47.1
x | Employees | 862 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.51% |
Latest transcript on Organogenesis Holdings Inc.
1 day | +5.58% | ||
1 week | +3.11% | ||
Current month | -3.64% | ||
1 month | +10.88% | ||
3 months | -4.68% | ||
6 months | -2.21% | ||
Current year | -35.21% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Gillheeney
CEO | Chief Executive Officer | 69 | 13-12-31 |
David Francisco
DFI | Director of Finance/CFO | 58 | 21-02-15 |
Patrick Bilbo
COO | Chief Operating Officer | 62 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Nussdorf
BRD | Director/Board Member | 69 | 02-12-31 |
Alan Ades
BRD | Director/Board Member | 85 | 02-12-31 |
Michael Driscoll
BRD | Director/Board Member | 63 | 22-02-14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 25 M€ | -3.43% | - | |
0.09% | 28 M€ | -2.42% | ||
0.03% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 2.65 | +5.58% | 1,821,882 |
24-06-04 | 2.51 | -3.46% | 1,136,994 |
24-06-03 | 2.6 | -5.45% | 5,718,932 |
24-05-31 | 2.75 | +0.73% | 1,035,151 |
24-05-30 | 2.73 | +6.23% | 2,910,560 |
Delayed Quote Nasdaq, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.21% | 333M | |
+55.70% | 55.7B | |
+41.08% | 39.91B | |
-5.39% | 39.57B | |
-5.56% | 28.16B | |
+16.46% | 26.3B | |
-20.56% | 18.94B | |
+33.03% | 12.17B | |
+25.85% | 12.12B | |
+2.72% | 12.12B |
- Stock Market
- Equities
- ORGO Stock